Complete remission achieved with single agent CNTO 328, an anti-IL-6 monoclonal antibody, in relapsed and refractory myeloma

Clin Lymphoma Myeloma Leuk. 2013 Jun;13(3):333-7. doi: 10.1016/j.clml.2012.12.010. Epub 2013 Jan 10.

Authors

Ajai Chari¹, Hadass Pri-Chen, Sundar Jagannath

Affiliation

¹ Department of Medicine, Division of Hematology/Oncology, Mt Sinai School of Medicine, New York, NY 10029, USA. ajai.chari@mssm.edu

PMID: 23313067
DOI: 10.1016/j.clml.2012.12.010

No abstract available

Publication types

Case Reports

MeSH terms

Adult
Antibodies, Monoclonal / administration & dosage
Antibodies, Monoclonal / adverse effects
Antibodies, Monoclonal / therapeutic use*
Female
Humans
Multiple Myeloma / drug therapy*
Recurrence
Remission Induction

Substances

Antibodies, Monoclonal
siltuximab